Indication expansion

Development

NetraMark and Juvenescence extend collaboration

Partnership sees AI platform expanded into drug repurposing and discovery. Canadian AI technology firm NetraMark yesterday announced the extension of its NetraPharma collaboration agreement with...
Danny Sullivan -
0
Read more
Indication expansion

Calico licenses memory-enhancing drug ISRIB

A new drug known as ISRIB which reverses Down's Syndrome memory deficits in mice has been licensed to Google’s Calico for aging research. In 2016...
Carla Heyworth -
0
Read more
Indication expansion

New study shows rapamycin slows Alzheimer’s

A new study from UT Health San Antonio suggests the drug rapamycin may be able to slow the rate of brain-related blood flow decreases. The...
Salvinija Roznyte -
0
Read more
Indication expansion

Anti-aging metformin brain drug works – but only in women!

Could metformin be made for women? The Longevity drug on the side of girl power. A new study has demonstrated that while metformin may have...
Eleanor Garth -
0
Read more
12Page 1 of 2

Latest articles

Insurer puts down £20m to research an aging rethink

Investment Carla Heyworth -
0
A new partnership between Legal & General and Edinburgh University aims to address the societal and economic implications of an aging society. The world is...
Read more

23andMe redundancies: DNA test market decline?

Gene editing Carla Heyworth -
0
Could layoffs at 23andMe be a sign that the consumer appetite for genetic testing is declining? We expect consumer markets to transition to more...
Read more

Singapore agetech – ones to watch in 2020

Independent living Eleanor Garth -
0
Singapore thrives on its prime location at the crossroads of Asia's biggest markets, low business tax and great IT infrastructure; it is well-positioned to...
Read more

Innovating organ-on-chip to accelerate research

Tissue/Organ Danny Sullivan -
0
BIOFABICS brings custom design tools to biofabrication. While still in its infancy, organ-on-chip (OOC) technology is quickly becoming a key growth segment in the Longevity...
Read more
TISSUE/ORGAN | NANOTECH | SENESCENCE | CELLULAR | DRUGS | AI | NEURAL | AGETECH | INVESTMENT

FREE NEWSLETTER SIGN-UP | LONGEVITY MARKET | ABOUT US | LOGIN | YOUR ACCOUNT | SHARE YOUR NEWS | CONTACT US

PRIVACY POLICY | COOKIE POLICY | TERMS AND CONDITIONS | COPYRIGHT POLICY

© Copyright 2019 PERGALI Limited. All rights reserved. PERGALI, Longevity.Technology and their associated logos are trademarks of PERGALI Limited and are the subject of trademark applications or registrations in various countries around the world. All other trademarks are the property of their respective owners. All PERGALI products and services are subject to continuous development. We reserve the right to alter technical specifications without prior notice.

Sign-up for daily news on the research, investments and technologies driving the Longevity market.

Sign-up for daily news on the research, investments and technologies driving the Longevity market.